Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

Elena A Nechaeva; Marina P Bogryantseva; Alexander B Ryzhikov; Olga G Pyankova; Tatyana Y Senkina; Irina F Radaeva; Sergey Y Nechaev; Natalya I Ryndyuk; Vladimir I Kuzubov; Zoya I Ginko; Irina V Kiseleva; Larisa G Rudenko

首页> 外文期刊>BMC proceedings. >Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

【24h】

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

机译：I期临床试验，安全性和免疫流感疫苗载体流感的免疫原性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《BMC proceedings.》 |2015年第s9期|共页
作者
Elena A Nechaeva; Marina P Bogryantseva; Alexander B Ryzhikov; Olga G Pyankova; Tatyana Y Senkina; Irina F Radaeva; Sergey Y Nechaev; Natalya I Ryndyuk; Vladimir I Kuzubov; Zoya I Ginko; Irina V Kiseleva; Larisa G Rudenko;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase 2162; randomized clinical trial in adults [J] . Song Joon Young, Lee Jacob, Woo Heung Jeong, Human vaccines & immunotherapeutics. . 2019,第3期

机译：卵子灭活的四价流感疫苗（GC3110A）的免疫原性和安全性与具有交替B株的两种灭活三价流感疫苗：2162阶段; 随机化的成人临床试验
2. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China [J] . Wang Shi-Yuan, Liu Shu-Zhen, Chu Kai, Expert review of vaccines . 2017,第7a12期

机译：在参与者> / = 3岁以下的灭活四价流感疫苗候选与灭活三价流感疫苗的免疫原性和安全性：中国的双盲，随机，平行控股第三阶段临床试验
3. Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity [J] . Frew Paula M., Paine Michele Bennett, Rouphael Nadine, Vaccine . 2020,第45期

机译：通过微针贴剂递送的灭活流感疫苗的可接受性：I临床试验的安全性，反应源性和免疫原性的结果
4. PRE-CLINICAL AND CLINICAL INVESTIGATION OF THE SAFETY AND IMMUNOGENICITY OF A NOVEL INTRANASAL INFLUENZA VACCINE [C] . R. Glueck International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：新型鼻内流感疫苗的安全性和免疫原性的临床前和临床调查
5. Skin response to immunogenic and non immunogenic material as applied to vaccine delivery and reconstructive surgery. [D] . Pendse, Pravada A. 2006

机译：皮肤对免疫原性和非免疫原性材料的反应，应用于疫苗输送和重建手术。
6. Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu [O] . Elena A Nechaeva, Marina P Bogryantseva, Alexander B Ryzhikov, 2015

机译：活文化流感疫苗载体-流感的安全性和免疫原性I期临床试验
7. Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu [O] . Elena A Nechaeva, Marina P Bogryantseva, Alexander B Ryzhikov, 2015

机译：活文化流感疫苗载体-流感的安全性和免疫原性I期临床试验

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

著录项

相似文献

相关主题

期刊订阅